These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11474673)

  • 1. Low-molecular-weight heparin in patients with deep-vein thrombosis.
    Stricker H; Mombelli G
    N Engl J Med; 2001 Jul; 345(4):292-3. PubMed ID: 11474673
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-molecular-weight heparin in patients with deep-vein thrombosis.
    Pechlaner C; Gritsch W
    N Engl J Med; 2001 Jul; 345(4):293. PubMed ID: 11474674
    [No Abstract]   [Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
    Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
    N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective.
    Hull RD; Raskob GE; Rosenbloom D; Pineo GF; Lerner RG; Gafni A; Trowbridge AA; Elliott CG; Green D; Feinglass J
    Arch Intern Med; 1997 Feb; 157(3):289-94. PubMed ID: 9040295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of deep venous thrombosis].
    Mesters RM
    Internist (Berl); 1999 Oct; 40(10):1098-9. PubMed ID: 10610366
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of venous thrombosis with low molecular weight heparin and fluindione].
    Fiessinger JN; Paul JF; Alhenc-Gelas M; Veyssier C; Martin JB; Aiach M
    Presse Med; 1992 Jan; 21(2):65-8. PubMed ID: 1311080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
    Kearon C; Ginsberg JS; Julian JA; Douketis J; Solymoss S; Ockelford P; Jackson S; Turpie AG; MacKinnon B; Hirsh J; Gent M;
    JAMA; 2006 Aug; 296(8):935-42. PubMed ID: 16926353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.
    Geerts WH; Jay RM; Code KI; Chen E; Szalai JP; Saibil EA; Hamilton PA
    N Engl J Med; 1996 Sep; 335(10):701-7. PubMed ID: 8703169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. What is the most effective blood thinner for treating patients with blood clots in the veins?
    Ann Intern Med; 2003 May; 138(9):I63. PubMed ID: 12729447
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems in laboratory monitoring of heparin dosage.
    Kitchen S
    Br J Haematol; 2000 Nov; 111(2):397-406. PubMed ID: 11122078
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose heparin thromboembolism prophylaxis.
    Owings JT; Blaisdell FW
    Arch Surg; 1996 Oct; 131(10):1069-73. PubMed ID: 8857904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duplex screening as a method of quality assurance of perioperative thromboembolism prophylaxis.
    Van Den Berg E; Bathgate B; Panagakos E; Lambrechts R; Hani M; Meissner A; Schröder M
    Int Angiol; 1999 Sep; 18(3):210-9. PubMed ID: 10688420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of thromboembolism in hip fracture: unfractionated heparin versus low molecular weight heparin ( a prospective, randomized study)].
    Platz A; Hoffmann R; Kohler A; Bischof T; Trentz O
    Z Unfallchir Versicherungsmed; 1993; 86(3):184-8. PubMed ID: 8130009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic indications for acute venous thromboembolism. Current status and future perspectives].
    Prandoni P; Simioni P; Pagnan A
    Minerva Cardioangiol; 2003 Aug; 51(4):361-71. PubMed ID: 12900718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention of pulmonary embolism].
    Minar E
    Acta Med Austriaca; 1992; 19(1):25-34. PubMed ID: 1316706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
    Paciaroni M; Ageno W; Agnelli G
    Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.